Notably, regarding the antibodies associated with dermatomyositis, in the Mi-2, NXP-2, SAE and TIF1γ groups, a relatively low frequency of ILD in IIM patients has been described in the literature. This evidence concerns the gene MORC3 and interstitial lung disease.